Men's Health: The World Market for Current and Emerging Drug Therapies

Attention: There is an updated edition available for this report.
 
   Single User - $2,625
   Hard Copy Mail Delivery - $2,625
   Corporate License - $5,250
   Online Download plus 1 Hard Copy - $2,850



Loading...
Published Aug 1, 2003 | 228 Pages | Pub ID: KLI888599

Special Offer. Now 25% off the original price of $3500.
This Kalorama Information report—Men’s Health: The World Market for Current and Emerging Drug Therapies—focuses on treatment segments in which men are affected. These segments include:

· Men’s Cancer

· Sexual Function

· Sexually Transmitted Diseases

· Urinary Conditions

· Andropause

The report covers drugs that are used for the treatment of conditions affecting men, including prostate cancer, impotence, and BPH; and areas where diseases and men’s health are a major concern including HIV, herpes, and urinary incontinence. Revenues for product segments include the amount estimated for use in men, for example in the area of BPH 100 percent of revenues are attributed to use in men and between 20 and 30 percent of the total urinary incontinence is calculated for the men’s health market.

The report includes statistical information for conditions and diseases affecting the men worldwide, with special emphasis on the U.S. market. Each segment provides an overview, descriptions of products on the market, products in research and development, market estimates and forecasts, and competitive analysis of leading providers. In addition to above-mentioned information, the report includes current issues and trends affecting the industry and identifies trends that may arise in the future.

In this report,  {{key}} appears {{searchResults.reportMatchCounts[value]}} times
We were unable to search inside this report.
No results matched your search criteria.

Search for an exact word or phrase by placing the word or phrase in quotation marks ("market trend"). Search for different versions or tenses of a word by placing an asterisk at the end of the word (pharma*).

Please note that your term must be at least three characters long and numbers will be blocked by the # sign.